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Abstract  
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Over the past 50 years there has been considerable progress in our understanding of biomolecular 
interactions at an atomic level. This in turn has allowed molecular simulation methods employing full 
atomistic modeling at ever larger scales to develop. However, some challenging areas still remain 
where there is either a lack of atomic resolution structures or where the simulation system is inherently 
complex. 
An area where both challenges are present is that of membranes containing membrane proteins. In this 
review we analyse a new practical approach to membrane protein study that offers a potential new 
route to high resolution structures and the possibility to simplify simulations. 
These new approaches collectively recognise that preservation of the interaction between the 
membrane protein and the lipid bilayer is often essential to maintain structure and function. The new 
methods preserve these interactions by producing nano-scale disc shaped particles that include bilayer 
and the chosen protein. Currently two approaches lead in this area: the MSP system that relies on 
peptides to stabilise the discs, and SMALPs where an amphipathic styrene maleic acid copolymer is 
used. Both methods greatly enable protein production and hence have the potential to accelerate 
atomic resolution structure determination as well as providing a simplified format for simulations of 
membrane protein dynamics.  
  
  
  
  
  
1. Introduction - The membrane protein dichotomy.  
Atomic resolution structures of proteins have revolutionised our understanding of many of the 
processes that underpin biology. The same structures have also enabled the growth of molecular 
simulation studies that have done much to uncover the complex structural dynamics that underpin 
protein function. However, progress across all protein classes has not been equal, with atomic 
resolution studies of membrane proteins, in particular, lagging significantly behind soluble proteins. 
For example extraction and purification of the first membrane protein (glycophorin A) did not occur 
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until more than 30 years after a similar feat was achieved for soluble proteins. The first high resolution 
structure of a membrane protein, that of the photosynthetic reaction centre, was not solved until 19841, 
nearly 20 years after this landmark was reached with soluble proteins2. This slow progress in the study 
of membrane proteins continues to the present day with only 1700 high resolution structures of 
membrane proteins compared to more than 110,000 of soluble proteins being found in the PDB in 
20153. This is despite membrane proteins having a clear and significant importance in biology The 
obvious question posed by this comparison is Why has success in studying membrane proteins been so 
limited cf. that of soluble proteins?  
 
1.1 The challenge of membrane protein extraction and purification.  
The real challenge in the production and study of membrane proteins occurs at the first step of the 
purification process: the need to separate the target protein from all other proteins present in the 
membrane. Over-expression of the chosen protein helps by increasing its proportion in the membrane, 
but to continue the purification process the membrane must be solubilised. Solubilisation of biological 
membranes is trivial using a detergent (or strictly speaking surface active agent, “surfactant”) will lead 
to a rapid fragmentation of the membrane. The resulting solution contains a heterogeneous mix of 
‘detergent/lipid’, ‘detergent/protein’ and ‘detergent only’ micelles. However, the general issue that has 
challenged membrane protein scientists for more than 40 years is that the target protein contained in 
the ‘membrane protein/detergent’ micelles often possesses low activity and/or stability. This makes the 
study of these proteins after purification very challenging.  
1.2 Complexity of the bilayer: Why are detergents an imperfect solution?  
At first sight the ‘detergent/protein’ micelle seems like the perfect solution. The protein is contained in 
a small particle made up of a reagent that has both hydrophobic and hydrophilic character. The 
hydrophobic moieties replace the acyl chains of the lipid in membrane stabilising the surfaces of the 
protein that naturally interact with the hydrophobic part of the membrane. The hydrophilic moieties 
ensure that the resulting mixed micelle is soluble in water. The real situation however, is somewhat 
different.   
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The first issue is that the membrane itself is a very complex structure made up of a number of physico-
chemically distinct layers.  It is in this complex layered environment that membrane proteins have 
evolved to function. This means that the outer surface of the membrane protein that is in contact with 
the membrane is not necessarily simply hydrophobic, but instead may contain polar amino acids which 
engage in complex interactions with the membrane in order to stabilise the conformation of the 
protein; perhaps most well-known of these being the positively charged arginine “snorkel”4. It is 
therefore clear that to maintain the activity of the protein any detergent system has to replicate this 
complex membrane structure as closely as possible. Such replication is seldom possible using the 
available detergents. This effect is further exacerbated when it is considered that most natural 
membranes are not made up of a single lipid type, but are mixtures of many different types of lipids. 
Such mixtures include phospholipids with different head-groups and acyl chains (varying in length and 
degree of unsaturation) as well as non-phospholipid constituents such as cholesterol. To replicate this 
is an almost impossible task for any single detergent or indeed combination of various detergents.  
A second major issue with detergent solubilisation is that detergents themselves have the potential to 
disrupt the intramolecular interactions within a membrane protein that are essential for structural 
integrity. The choice of a detergent therefore always involves maintaining a delicate balance between 
successful solubilisation and retention of the target membrane protein’s native structure. In practice 
this is very rarely achieved using detergents.  
1.3 A new dawn in membrane protein solubilisation  
In this review we discuss a range of new approaches to the production of membrane proteins that 
recognise the importance of the lipid bilayer in determining the correct structure and function of said 
species. These methods aim to preserve the lipid bilayer in the locality of the protein with the aim of 
preserving ‘native-like’ activity and stability. We describe how these techniques have developed from 
early proofs-of-concept that still require some use of detergent through to the most recent methods that 
dispense with detergent entirely. In the latter part of the review we describe how a wide range of 
structural and biochemical analytical techniques can be applied to the study of SMALP-encapsulated 
membrane proteins, and finally argue that the time is now ripe for these new particles to be the basis 
for molecular simulation studies.  
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2. The role of nanoparticles in membrane protein purification  
In recent years, the basic format of an amphipathic molecule capable of solubilising a lipid bilayer 
and/or maintaining membrane proteins (MPs) in solution has been radically reinterpreted. The first 
development was amphipols (APs), amphipathic polymers invented by Popot5 and coworkers that have 
been shown to bind tightly to MPs and preserve their solubility in water. Like detergents, APs largely 
replace the lipid bilayer leaving a protein/AP particle that is analogous to the  protein/detergent 
micelle. More recently methods have been developed that attempt to preserve the membrane context 
around the protein. By achieving this scientists aim to more effectively preserve protein stability, 
structure and function.. At the forefront of this new movement are groups that have developed systems 
that extract disc shaped particles from membranes. These new particles share a common format: the 
MP sits in a disc-shaped piece of membrane (generally close to 10 nm in diameter) that is stabilised by 
a reagent that interacts with the edge of the disc. Two systems currently lead in this area and utilise 
different methods for stabilising the particles. First to show utility were groups that used membrane 
scaffold proteins (MSPs) as stabilising agents while later on the scene have been groups that use an 
organic polymer based on styrene maleic acid (SMA). In the next section both systems will be 
analysed. 
2.1 Membrane scaffold protein (MSP) nanodiscs   
The development of nanodiscs as a method for MP encapsulation was first reported in 2002 by 
Stephen Sligar and co-workers. Their nanodisc system contains three components,: the MP, a lipid 
bilayer and an amphipathic helical protein termed a membrane scaffold protein (MSP)6.  
MSPs are peptides derived from the human serum apolipoprotein A1. They consist of 22 residue 
peptides that form helical repeats punctuated by proline and glycine. When incorporated into 
nanodiscs it is thought that two molecules of MSP encircle a lipid bilayer (with embedded MP) 
forming a stabilizing belt around the nanodisc. Research has shown that the length of MSP used to 
produce the nanodiscs can be varied. When combined with different lipid contents the size of the 
resulting nanodisc can be controlled to give discs with diameters between 9.8 nm to 12.8 nm7.   
Since the first description of the MSP system6, Sligar and colleagues subsequently demonstrated its 
successful application with a diverse range of MPs, including bacteriorhodopsin8, GPCRs9, cholera 
toxin10, coagulation factors11, cytochrome P45012,13 and TAR receptor14. By showing this wide utility 
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Sligar and co-workers established  the importance of nanodisc approaches in studies of MPs. 
However, close examination of the method used to make MSP nanodiscs highlights a significant 
limitation: the process relies on the solubilisation of the protein in a traditional detergent. Following 
purification, MPs are reconstituted along with lipid into the MSP discs. Therefore despite containing 
lipids,  MSP nanodiscs are unlikely to represent the native lipid bilayer. Once lost it is very difficult, if 
not impossible, to recreate this unique environment.   
2.2 Styrene maleic acid lipid particles (SMALPs)  
MSP nanodiscs undoubtedly offer a solution, imperfect though it may be, to studying MPs in a lipid 
supported environment.  More recently, a new method has emerged that employs ‘styrene maleic acid 
copolymer (SMA)’ to extract proteins from membranes15. Similar to the MSP system the resulting 
particles are disc-shaped, containing lipid and protein encircled by a belt of polymer, in this case 
SMA. Knowles and co-workers15 first reported the use of SMA in the purification of PagP and 
Bacteriorhodopsin, and the phrase ‘styrene maleic acid lipid particles (SMALPs)’ was coined to 
describe the nano sized disc shaped particles formed in the process. Subsequently Orwick-Rydmark et 
al16 used a related SMA polymer (containing a ratio of 3:1 Styrene to Maleic acid cf. 2:1 used in the 
Knowles study) to solubilise a MP in a particle they called a Lipodisq™. The major difference 
between the SMA- and MSP-based methods is that SMA polymers can be used to excise MPs directly 
from membranes, without at any stage in the protocol employing traditional detergents(Fig.1). This 
means that the MP is effectively co-purified with its native lipid environment, providing a near-perfect 
solution to the production of MPs. The following sections discuss aspects of the SMA-based isolation 
system.  
 
 
 
 
Figure 1. A comparison of SMALPs, MSP- nanodiscs, and amphipols for membrane protein 
purification.  
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3. Biophysical characteristics of SMALPs  
A key question about lipid nanoparticles is  ‘do these small disc-shaped pieces of lipid truly replicate 
the properties of the larger lipid continuum?’ In order to answer this question, one must consider what 
physical characteristics define a lipid bilayer. For simplicity this can be considered in two ways. 
Firstly, the structural details of the bilayer,pertinent questions to address here are the following:   
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● Is the overall organisation of the bilayer in the disc the same as that in the membrane 
continuum?  
● Are the hydrophilic head groups at the surface and the acyl chains buried in the core?   
● Is the bilayer a planar structure? Or is it curved in some way?  
The second aspect requiring consideration is bilayer dynamics. Here two main questions come to 
mind:   
● Are the lipids free to diffuse?  
● Are the various phase transitions exhibited by lipid bilayers preserved?   
In the following section we discuss each of these in turn, using where available relevant examples 
from the literature.  
3.1 The structure of SMALPs  
Studies of SMALPs using small angle X-ray (SAXS) and neutron (SANS) scattering measurements 
show that the particles are indeed disc shaped. Measurements of the height of the disc (a dimension 
that should replicate that of an intact bilayer) provide a dimension that is similar to that of a bilayer 
formed of the equivalent lipid17 (Figure 2a). Distinct headgroup and tail regions, characterised by 
different scattering length densities, can be discerned from these data, as well as a region filled with 
the hydrated polymer belt encircling the hydrophobic region at the edge of the disc. The SMALP discs 
appear to have a circular cross-section, in contrast to the elliptical cross-section reported for MSP-
stabilized nanodiscs17,18 17,18Figure 2b). This may be due to the larger degree of flexibility inherent in 
the polymer chains wrapping the lipid bilayer tails cf. that of the MSP, which has a defined secondary 
structure. SAXS and SANS experiments indicate that when prepared using the commercially available 
SMA polymer, the discs have a maximum diameter of 9.8 nm, while TEM images of dried nanodisc 
solutions stained with uranyl acetate show a bimodal population consisting of 11.1 ± 3.3 nm and 16.0 
± 3.0 nm objects17. This difference may be due to the orientation of the discs on the EM grid, capture 
of fluctuating objects via the drying procedure, and/or effects of the staining process cf. the time- and 
rotationally-averaged solution structures measured in scattering experiments17. 
Both SAXS/SANS and ATR-FTIR suggest that in the case of SMA-stabilized discs there is some 
penetration of the hydrophobic moieties of the polymer into the tail region of the lipid bilayer. In 
particular, data from polarised ATR-FTIR17 shows that the styrene side chains of the SMA polymer lie 
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with their long axes parallel to the long axis of the lipid acyl chains. This implies some form of 
intercalation analogous to that observed when cholesterol interacts with the acyl chains of 
phospholipids17. Taken collectively these studies confirm that the dimensions of the bilayer 
encapsulated within the SMALP replicate those observed in intact cell membranes.  
One unanswered question is whether the lipids simply fill the available space within the bounds of the 
encircling stabilizer, with dimensions set by the stabilizer (which appears to be the case for MSP 
stabilized discs)19,20, or whether the stabilizer adjusts to encompass available lipids. The latter case, 
which appears to apply to SMA stabilized discs21, is an equilibrium structure driven by line-tensions, 
molecular and bilayer curvature, and hydrophobic and hydrogen bonding This is a question that may 
be addressed by molecular dynamic simulations and is revisited in Section 5.   
 
3.2 Phase transition behavior of lipid bilayers in discs 
The phase behaviour of the lipids is the final aspect to consider when assessing whether a membrane 
encapsulated within a disc system (SMALP or MSP) mimics the lipid continuum. It has long been 
known that lipid bilayers undergo a range of phase transitions, the most physiologically important 
being the gel to liquid transition. The mid-point temperature of this transition has significant 
importance for MP function, in particular for those proteins where a conformational change is an 
essential part of function. For example, in the gel phase motions within and between individual lipids 
are much reduced. This has the effect of inhibiting any motions within a MP that might require a 
rearrangement amongst lipids close to the protein. In contrast, above the lipid transition temperature 
(in the liquid phase) there is an enhancement in the motions of the phospholipids, which has the 
potential to enable protein conformational changes to take place. It is therefore clear that should a 
membrane encapsulation system, such as those described here, change the transition temperature to 
any significant degree it could greatly alter the activity of the encapsulated MP. This is particularly 
pertinent for any membrane systems that exhibit a transition near room temperature (for example the 
transition temperature of DMPC is 24 oC), where even small change in transition temperature could 
significantly change the outcome of an experiment.  
To assess the effect of encapsulation on lipid phase behaviour, differential scanning calorimetry (DSC) 
provides the gold standard (although Denisov et al. have complemented such measurements with 
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Laurdan generalised polarisation20). Using DSC significant studies have been made of the two major 
encapsulation methods (SMALP and MSP), as well as some analysis of the effect of subtle changes to 
each individual encapsulation reagent itself, e.g. looking at the effect of changes in styrene:maleic acid 
ratio used in SMALP formation. In the majority of studies one common observation is made. When 
unencapsulated lipid bilayers are studied using DSC the transition is very sharp, indicating that the 
phase transition has a very high degree of cooperativity. This is unsurprising given that the transition 
reflects a state change much like the melting of ice. However, similar transitions observed in 
encapsulated systems show a much broader change indicating a lower level of cooperativity. This is 
also not surprising given that the encapsulated system consists of isolated pieces of bilayer, which in 
general contain less than 150 lipid molecules. This is small cf. the number of cooperative units 
generally observed in lipid bilayers which extend into many thousands of lipid molecules. It is also 
possible that some element of this change may indicate that, of the 150 lipid molecules, those around 
the edge interact more strongly with the encapsulation system, which in the case of SMA involves 
interactions with styrene groups. These interactions may dampen the phase transitions of these lipids 
(effectively freezing them out) meaning that the effective number of lipid molecules that undergo the 
transition in the disc is significantly less than 150.  
The second observation made from DSC data concerns the transition temperature itself. Compared to 
the observations made on the shape of the transition, it is here that different characteristics of the 
encapsulation system become apparent. A very comprehensive study of two MSP encapsulation 
methods by Denisov20 showed that for DMPC and DPPC discs the phase transition temperature stays 
relatively close to that observed for the free bilayer. The discs made with DMPC displayed a phase 
transition close to 29 oC cf. 24 oC for the free bilayer, while the figures for DPPC discs are 
approximately 43.7 oC cf. 41 oC for the free bilayer. Interestingly, in both cases the transition 
temperatures in the disc are higher than that observed in the lipid continuum, suggesting that in some 
way the encapsulation inhibits melting of the bilayer. This could be either related to the interactions 
between the side chains of the encapsulation polymer and the lipids (as mentioned earlier), or 
alternatively result from some form of lateral compression of the membrane in the disc. Of the two 
explanations for the elevated transition temperature increased lateral compression is the more likely; 
given that the same effect is observed for larger discs formed using a different MSP. If side chain 
interactions were important then these larger discs should show a smaller effect as the ratio of outer 
lipids to inner lipids is reduced.  
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Similar studies have also been carried out for the SMALP system by ourselves17 and others22. The 
earlier study carried out by Orwick et al. employed SMA with a 3:1 styrene: maleic acid ratio, and 
here again a broad temperature transition was observed. In the same report Orwick and co-workers 
described a reduction in the transition temperature for a DMPC disc of some 10 oC. One explanation 
for this reduction in transition temperature is that some  disruption of the bilayer structure occurred 
which is likely related to higher styrene content of the SMA reagent employed. In comparison the later 
study, which used 2:1 ratio SMA polymer showed the smallest perturbation of the phase transition 
temperature of all the systems analysed amounting to decrease of 1 oC.   
Some variation in the physical characteristics of the bilayers encapsulated in different systems aside,  
drawing all available data together clearly indicates that SMAs with a styrene: maleic acid ratio of a 
2:1 perturb the bilayer to the smallest degree. In view of this observation the next section highlights 
the use of the SMA 2:1 SMALP system in the study of a range of MPs.  
 
 4. Use of SMALPs in the production of membrane proteins  
Since its discovery the SMALP system has been used to produce a wide range of MPs. The technique 
has been shown to be versatile not only for MPs that are recombinantly expressed in a variety of 
prokaryotic and eukaryotic systems, but also for MPs from natural sources. In all of these examples, 
protein has been produced without the use of detergents at any stage during the protein purification 
process (Table 1). The MPs that have been successfully extracted using SMA include a range of 
structures including β-barrel and α-helical transmembrane (TM) regions, sizes from a single TM α-
helix up to 36 TM helices, and functions including transporters, channels, GPCRs and enzymes. 
(Figure 2c-d) 
Once proteins have been removed from the membrane in a SMALP, the advantage of this method is 
that they can then be treated like a soluble protein during purification. Using  affinity tags, such as 6 - 
8 × HIS tag, purification of the protein of interest can be achieved via immobilized metal affinity 
chromatography (IMAC) followed by size exclusion chromatography (SEC).  
One of the unique features of the SMA approach is that the protein is extracted directly from a 
membrane with its annular lipids. As mentioned previously, the function of many MPs is highly 
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dependent on their membrane environment and may require interactions with specific lipid species. 
Several studies have shown that the lipids within purified SMALPs can be extracted and analysed23–26, 
meaning it is possible to determine if a protein associates with a specific subset of the bulk lipids. Such 
insights are likely to be important for a more complete understanding of MP function or localisation. 
For example, it is possible that such studies could compare the annular lipids of a protein from 
‘healthy’ versus ‘diseased’ tissues. A second feature of the SMA approach is that it is possible to 
isolate native complexes. If the proteins interact in the native membrane (and assuming the complex is 
not too large for a SMALP) then they can be co-extracted from the membrane23,27.  
There does appear to be a maximal size of protein/complex that can be extracted using SMA, simply 
because the size of the disc formed is limited, and the protein needs to fit within it. However, 
interestingly SMALPs have been used indirectly to purify a large complex of photosystem I-Light 
harvesting chlorophyll II from spinach thylakoid membranes. The PS I-LHC II complex is too large 
for the SMALP size, but instead researchers used SMALP solubilisation to remove key contaminants 
from the membrane, leaving a membrane preparation highly enriched for the complex28.   
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Figure 2.  
Comparison of membrane proteins in nanodiscs; a) Lipid-only SMALP, illustrating the dimension of 
the SMA belt and how the styrene  groups of the polymer intercollate with lipid17; b) MSP showing 
lipid-only nanodisc, formed using two molecules of MSP1 two discs of different sizes are shown, 
MSP1E3 is used to create a larger size nanodisc which can  accommodate the membrane protein 
Bacteriorhodopsin7;c) Negative stain 3D reconstruction of SMALP AcrB, accommodates 36 
transmembrane helices29 d) Cryo-Em 3D reconstruction of SMALP P-glycoprotein ABCB130.   
 
 
4.1 Structural and functional studies of membrane proteins encapsulated in SMALPs  
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The size and stability of the SMALP structure makes them amenable for many techniques used to 
study protein structure and function. When a protein is encapsulated in a SMALP both sides of the 
membrane are freely available in solution, which is advantageous for studies of ligand binding. This is 
quite unlike crude membranes or reconstituted proteoliposomes, where one side is not exposed to bulk 
solvent. Proteins encapsulated into SMALPs have been successfully used to study ligand binding to a 
range of different proteins, including GPCRs and transporters, and it has been shown that binding 
parameters are comparable to those observed in the natural membrane29–31.   
The small size of the SMALP particles means that unlike membranes or proteoliposomes they do not 
scatter light, and further, they contain a higher ‘protein: lipid’ ratio than proteoliposomes, attributes 
which are helpful for spectroscopic techniques. SMALP-encapsulated proteins have been studied using 
a wide range of spectroscopic techniques including absorbance spectroscopy15,26 and fluorescence 
spectroscopy, utilising approaches such as tryptophan quenching, quenching of exogenous fluorescent 
labels and FRET23,29,30. Unlike MSPs, which use a protein ‘belt’, the SMA polymer does not interfere 
with spectroscopic measurements such as circular dichroism (CD), enabling study of the secondary 
structure and stability of MPs15,24,30,31. In recent years DEER-EPR (double electron-electron resonance 
- electron paramagnetic resonance) has been the applied to the study of changes in long range 
distances between residues that result from protein conformational changes. In these studies the lipid 
nanodisc structure (both MSP and SMALP), has been shown to improve signal quality cf. 
proteoliposomes, without sacrificing the  lipid bilayer environment16,32,33. This data provides useful 
distance constraints for molecular modelling34.  
Structural studies of MPs in SMALPs have been successfully carried out using single particle electron 
microscopy (EM), using both negative stain29 and cryo methods30 (Figure 2c-d). One of the 
advantages of electron microscopy is that it does not require crystallisation of the protein and uses 
relatively small amounts of sample. Notably the SMA polymer does not dominate EM images cf. 
observations with particles using the MSP protein scaffold29. Given the recent technical advances in 
both generating and processing EM images it is quite plausible to think that atomic resolution 
structures will be achievable using the SMALP system in the future35,36. The application of other 
structural techniques to SMALP encapsulated proteins has yet to be demonstrated, although SAXS and 
SANS approaches should work well given the stable, monodisperse nature of the samples, and their 
track record for studies of lipid-only SMALPs17.  
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Whether SMALP purified protein can be used to generate crystals is yet to be determined The signs 
are promising: proteins in SMALPs can be more easily concentrated than in detergents, generally 
display greater purity, and are monodisperse.  One concern is whether the polymer can be easily 
removed without disrupting the protein; this remains to be seen.  
 Table 1. Comparison of the proteins purified using SMALPs. 
Name TM structure Family/ 
function 
Source Recombinant 
/native 
Polymer 
ratio S:M 
Purified Functional 
assay 
Ref. 
PagP 8-stranded β-
barrel 
Outer 
membrane 
enzyme 
Purified, 
reconstituted 
proteoliposome
s 
Native (E. coli) 2:1 n/a Enzyme 
activity 
(phospholipase
) 
15 
Bacteriorhodopsin 7 TM α-
helices 
Light-
driven 
proton 
pump 
Purple 
membrane 
from 
Halobacterium 
salinarum 
Native 2:1 
and 
3:1 
Size 
exclusion 
Spectroscopic 
characteristics 
15, 16 
Respiratory 
complex IV 
19 TM α-
helices 
Cytochrome 
c oxidase 
Mitochondria 
from S. 
cerevisiae 
Native 3:1 - Enzyme 
activity 
(ferrocytochro
me c 
oxidation) 
26 
KCNE1 1 TM α-helix Modulates 
function of 
certain Kv 
channels 
Purified, 
reconstituted 
proteoliposome
s 
Recombinant  
(E. coli) 
3:1 n/a - 33 
P-glycoprotein 
(ABCB1) 
12 TM α-
helices 
Multidrug 
efflux, ABC 
superfamily 
High Five 
insect cell 
membranes 
Recombinant 2:1 Nickel 
affinity 
Ligand 
binding 
(fluorescence) 
30 
MRP1 (ABCC1) 17 TM α-
helices 
Multidrug 
efflux, ABC 
superfamily 
H69AR human 
cancer cell line 
Native 2:1 Immuno-
affinity 
Ligand 
binding 
(radioligand) 
30 
MRP4 (ABCC4) 12 TM α-
helices 
Multidrug 
efflux, ABC 
superfamily 
Sf9 insect cell 
membranes 
Recombinant 2:1 Nickel 
affinity 
- 30 
ABCG2 (BCRP) 2 x 6 TM α-
helices 
Multidrug 
efflux, ABC 
superfamily 
High Five 
insect cell 
membranes 
Recombinant 2:1 Nickel 
affinity 
Ligand 
binding 
(fluorescence) 
30 
CFTR  12 TM α-
helices 
Chloride 
channel, 
ABC 
superfamily 
S. cerevisiae 
membranes 
Recombinant 2:1 Nickel 
affinity 
- 30 
PBP2/PBP2a 1 TM α-helix 
each 
Penicillin 
binding 
proteins 
S. aureus 
whole cells 
Native 2:1 Immuno-
precipitat
ion 
- 27 
Photoreaction 
centre 
11 (5 + 5+ 1) 
TM α-helices 
Charge 
separation 
during 
Purple 
bacterium 
Rhodobacter 
Recombinant 2:1 Nickel 
affinity & 
size 
Charge 
recombination 
(spectroscopic) 
25 
16 
photosynthe
sis 
sphaeroides exclusion 
KcsA 4 x 2 TM α-
helices 
Potassium 
channel 
E. coli whole 
cells 
Recombinant 2:1 Nickel 
affinity & 
size 
exclusion 
Planar bilayer 
electrophysiolo
gy 
24 
AcrB 3 x 12 TM α-
helices 
Multidrug 
efflux, RND 
family 
E. coli 
membranes 
Recombinant 2:1 Cobalt 
affinity 
Ligand 
binding 
(fluorescence) 
29 
A2AR  
(adenosine 2A 
receptor) 
7 TM α-
helices 
G-protein 
coupled 
receptor 
P. pastoris 
membranes 
Recombinant 2:1 Nickel 
affinity & 
size 
exclusion 
Ligand 
binding 
(radioliagnd) 
31 
SecYEG 15 (10 + 3 + 2) 
TM α-helices 
Protein 
translocatio
n 
E. coli 
membranes 
Recombinant 3:1 Nickel 
affinity 
Substrate 
binding 
(FRET) 
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ETK  2 TM α-
helices 
Tyrosine 
kinase 
E. coli 
membranes 
Recombinant 3:1 Nickel 
affinity 
Auto-
phosphorylatio
n 
37 
TSPAN7 4 TM α-
helices 
Tetraspanin S. cerevisiae 
membranes 
Recombinant 3:1 - - 38 
 
 
5. Opportunity for use in Molecular Simulation  
Molecular dynamics (MD) simulations can yield a picture of the dynamics of proteins in a 
range of environments at physiologically relevant temperatures. MD simulations of MPs are a 
relatively recent addition to an established history of MD simulations of proteins in general; 
nevertheless they have already proven to be a successful addition to the toolkit for studying biological 
membranes and the proteins that are associated with them39,40. Currently MD simulations are routinely 
used to study the evolution of a molecular system on microsecond timescales (we note that timescales 
that exceed these have been reported, but these usually require custom-built hardware)41–43.   
MD simulations are based on classical mechanics. The components of the simulation system (protein, 
lipids, water, etc.) and their interactions are described by a suitable molecular mechanics force-field. 
The force-field provides a link between the positions of particles in a molecular system and  the 
potential energy of that system. Numerical integration of Newton’s equations of motions for every 
atom or particle in the system enables the positions of the atoms to be recorded at suitable intervals 
yielding a trajectory, which describes the time evolution of the protein, lipid, and water molecules. 
Analysis of the trajectory in terms of e.g. protein conformational rearrangements, protein/ligand and 
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protein/lipid interactions, are then typically performed offline. Thus MD provides an ideal complement 
to structural and biophysical methods of characterising MPs. 
Traditionally MD simulations of MPs have been performed at the atomistic (AT) level of resolution, 
where each atom is explicitly considered (with the exception of 'united atom' models in which non-
polar hydrogen atoms are considered implicitly)44. These simulations have been successful for 
elucidating details of e.g. protein-ligand interactions, protein conformational changes that occur on 
nanosecond to microsecond timescales and for aiding the design of mutations for a range of 
applications. Coarse-grain simulations (CG), in which a number (usually ~ 4 as in e.g. the MARTINI 
force field) of heavy atoms are grouped together into pseudo-atoms, enable simulation of larger 
systems than atomistic simulations and also allow access to longer timescales at the cost of explicit all-
atom detail45,46. Such models enable simulation of self-assembly processes and exploration of protein-
membrane interactions that occur over many microseconds. Traditionally, one of the gaps between in 
vitro and in silico experiments of MPs has often been in the size of system studied, with in vitro  
usually being much larger than in silico. This  is another issue that enhances the complexity of 
studying MPs as compared to their soluble cousins. In the latter case the system to be simulated needs 
only be a protein in a homogenous solvent. While for a MP there is the added need for a stable 
membrane, which in itself is chemically heterogenous alongside the aqueous solvent and the protein. 
To add more complexity a discrete portion of the membrane cannot be simulated as the effects of 
having exposed acyl chains at the edge of such a construct leads to instability. This means that either 
very large simulations that includes a vesicle (therefore lacking any edges) or implementation of 
periodic boundary conditions to simulate a membrane continuum. A key advantage of any of the disc-
based systems is that they naturally bridge this gap; the nanodiscs are small enough to be simulated 
using MD, given they are ~ 10 nm in diameter and composed of ~ 120 lipids. This is well within the 
capabilities of state-of-the-art MD simulations at both the atomistic and CG levels.  
In the context of the discussion above, it is useful to review the nanodisc simulations studies reported 
in the literature; these have included both atomistic and CG MD methodologies. Shih et al reported 
some of the earliest molecular dynamics simulations of MSP nanodiscs47. They performed atomistic 
simulations of nanodiscs composed of DPPC phospholipids surrounded by various lengths of the 
truncated human scaffold protein MSP1 (which contains the 200-residue lipid-binding C-terminal 
domain of apolipoprotein A-1). The nanodisc models were based on the earlier modelling and 
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simulation work of Klon et al.48. The nanodiscs contained 160 lipids, 80 in each leaflet of the bilayer 
and two belts of scaffold proteins. The initial alignment of the scaffold proteins proved to be rather 
crucial in these simulations as the restricted timescales accessible to atomistic simulations did not 
allow for realignment of the proteins in a more favorable configuration and thus out of plane 
deformations were observed with some lengths of scaffold protein. Interestingly, embedding 
bacteriorhodopsin, an integral MP into the nanodiscs did not induce out of plane deformations, 
however these discs did adopt a more rectangular overall morphology. 
The authors concluded that while atomistic simulations timescale of nanoseconds, allow for the 
relaxation of the scaffold protein, they are not long enough to observe any potential changes in the 
scaffold protein alignment. Encouragingly, these simulations did show the potential utility of MD 
simulations in the future design of improved scaffold proteins. 
To overcome the timescale limitations of atomistic simulations, in 2006 Shih et al reported a new 
coarse-grain (CG) protein-lipid model developed specifically with the aim of studying large, nanoscale 
systems49.  One aspect of SMALP nanodisc structure where MD simulation can provide 
unprecedented levels of information is the self-assembly of the discs. To this end, in a subsequent 
paper the CG model was employed to study the self-assembly of high-density lipoprotein (HDL) 
nanoparticles from microsecond timescale simulations50. HDL assembly was found to proceed via two 
broad stages; firstly the aggregation of proteins and lipids driven by the hydrophobic effect was 
observed to occur over ~ 1 microsecond, this was followed by the optimization of the protein 
localisation and orientation, which is driven by increasingly specific protein–protein interactions 
which lead to the ordered 'double belt' arrangement that is characteristic of scaffold proteins in 
nanodiscs. 
Recently,Debnath and Schäfer reported study of nanodiscs composed of DMPC phospholipids, 
surrounded by a 'belt' composed a major scaffold protein from human apolipoprotein A-151. Self-
assembly of the lipids and protein into nanodiscs was studied by CG-MD. Simulation of the nanodiscs 
at both atomistic and CG resolutions revealed that while on average lipids in the nanodisc have lower 
configurational entropy and higher acyl tail order than in a lamellar bilayer phase, the actual dynamic 
behaviour depends very much on the location of the lipids within the nanodisc. Lipids located at the 
centre of the nanodisc are highly ordered, whereas lipids that are in contact with the MSP proteins at 
the outer rim of the nanodiscs are highly disordered, due to disrupted packing.  This study illustrates 
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the unique advantages of probing lipid behaviour within nanodiscs by molecular dynamics simulation. 
Vestegaard et al. reported a coarse-grain MD study, in which the properties of nanodiscs, bicelles and 
flat bilayers were compared. Their results showed that the extent of peptide solvation within bicelles 
and nanodiscs is strongly dependent upon location of the peptide within the membrane mimetic 
environment and that dynamics of membrane mimetics can be rather different when proteins are 
embedded compared to the protein-free environment. This observation is in agreement with other 
molecular dynamics simulations studies, which have also revealed the complex interplay between 
proteins and lipids52,53. 
While, to our knowledge there are only a few reported molecular simulation studies of SMALPS 
nanodiscs to date (two papers not discussed here are54,55), the field of nanoparticle simulation in 
general is growing at a rapid rate.  Numerous studies of the interaction of fullerenes, carbon nanotubes, 
and dendrimers with lipid bilayers have been published in the last few years 56–60. In addition, the 
state-of-the-art in terms of size and complexity of atomistic and coarse-grain membrane models is also 
rapidly increasing. At the atomistic level, studies of bacterial membranes in particular are now 
regularly incorporating the asymmetry and mixed lipid composition of in vivo membranes61,62. 
Similarly, at the coarse-grain level, state-of-the-art models of eukaryotic membranes now incorporate a 
range of lipids and multiple copy numbers of integral MPs52,63. 
5.1 The opportunities available using SMALP based simulations. 
It is clear that the discrete nature and small unit size of disc-shaped encapsulation systems like 
SMALPs and MSPs provides a clear advantage for MD simulation approaches.  However there are a 
number of practical aspects of these systems that have the potential to provide information that can be 
utilised by in silico modellers. In the following sections we highlight some of these opportunities. 
Over the past few years biophysical data on both SMALP and MSP systems has begun to appear. In 
the case of the MSP system some MD simulation work has begun to unravel some of the fundamental 
aspects of the MSP structure and that of proteins contained within the particle. Similar work on the 
SMALP system is, in contrast, still very much in its infancy. Studies of SMALP structure so far 
carried out (and reviewed in previous sections) provides a number of  observations that are testable in 
MD systems. For example the arrangement of the SMA chain with respect to the bilayer, including the 
orientation of the styrene moieties with respect to the acyl chains, the size and stability of the particle 
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itself and the influence of maleic acid charge on the structure. Some of these questions are clearly 
answerable using atomistic simulations but some, notably self-assembly of the particle itself, could 
require CG approaches. It is clear that in an ideal world these investigations should be carried out 
before those on protein loaded SMALPs to provide confidence that the simulations protocols 
adequately represent the basal particle. 
Once these simulations have been established then other aspects of the SMALP system will be ripe for 
exploitation. The discrete nature of these disc system also means that there is some control over the 
lipid make-up of the bilayer in the particle. Recent published work24 has shown that the lipid content 
with the disc can be determined to some degree. Our own recent unpublished work shows that 
application of the relevant mass spectrometry methods to SMALPs can provide details on the 
abundance of lipids with different headgroups and acyl chain types in the particle. Availability of this 
information means that simulations can be set up with more certainty that the membrane being 
simulated better matches reality. Over the last few years, MD simulations have also been particularly 
successful in identifying important lipid-protein interactions, especially in mixed lipid systems. Often 
these in silico experiments are difficult to replicate as generating membrane systems with new lipid 
makeups can be challenging.  The reversibility of the SMALP system which allows easy transition 
between vesicle and disc forms means that lipid exchange experiments could be accomplished with 
more ease and certainty. For example a SMALP protein preparation could be returned to a vesicle state 
(by reducing pH to 6, which is below the pKa of SMA). Addition of a different lipid combined with 
some form of agitation will allow the formation of mixed vesicles that can be returned to the SMALP 
state by raising the pH. If the protein containing SMALPs are then separated (by simple affinity 
chromatography) then the mass spectrometry methods detailed above can be used to confirm the lipid 
exchange.  
In addition to the reduced system size, a number of other properties make SMALPS and MD 
simulations ideal complementary techniques. For example it is practically possible to produce 
materials that contain differing numbers of proteins in a single SMALP. The activities of these 
materials can be tested and then compared to simulation. This would be particularly advantageous for 
studying the effect of monomerization/oligomerization on MP function, as the copy numbers of the 
proteins can be tightly controlled in both techniques. Membrane proteins have been demonstrated to 
have an increased stability and activity when immobilised in SMALPS nanodiscs when compared to 
21 
detergent-based methods. Given the short timescales accessible to MD simulations, this increased 
activity provides  advantages when comparing data from experimental and computational methods.   
Perhaps the most exciting opportunity for the future comes from the combination of new atomic 
resolution EM techniques with SMALPs and MD simulation. As has already been demonstrated 
SMALP-MP complexes seem to be well suited to study by EM. The advent of direct detection EM and 
hence the potential for near atomic resolution data provides a potentially rapid route to structural data 
sets that contain both protein and lipid. These provide almost ideal starting points for MD studies. 
Cryo-EM can also provide “snapshots” of the conformational subforms that are present in solution, 
unlike X-ray crystal structures that provide a single conformational form. This could provide MD 
simulation experts with snapshots in real trajectories, and statistical data as to the prevalence of those 
subforms in the bulk. As can be imagined such directly observed datasets provide ideal data for 
assessing MD simulation performance. 
Thus, it can easily be envisaged that in the future MD simulation and experimental techniques will be 
used in conjunction with each other to obtain complementary insights into the dynamic behaviour of 
proteins embedded within SMALPs nanodiscs and to design novel scaffold proteins. 
 
6. Conclusion.  
For the latter part of the twentieth century membrane protein purification relied almost entirely on the 
use of detergents in order to produce pure preparations of these important biomolecules. These times 
were often intensely frustrating for the membrane biologist, with only a small subset of the membrane 
proteome being amenable to purification using detergent methods. Since the millennium a number of 
new approaches have appeared that aim to resolve the detergent issue. In this review we have charted 
the development of these new methods which have valued the retention of the lipid bilayer in the final 
membrane protein preparation. The latest chapter in this story has been the establishment of the 
SMALP method that removes the need for detergent entirely, ensuring that the local environment 
around the membrane protein is preserved. With the establishment of this method researchers can look 
forward to an era of new opportunities where large previously intractable parts of the membrane 
proteome become available for study. Inevitably this will lead to an expansion in our knowledge of the 
structure of MPs at the atomic level, which will make a plethora of simulation studies possible. 
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However, it is also clear that use of discrete proteolipid particles to solve this historical bottleneck 
offers even more to the molecular simulator. These new particles have the potential to provide 
structural data on not just the protein, but also the local membrane, an element almost entirely missing 
from existing structures of MPs. In addition, the relative simplicity of these systems (containing less 
than 150 lipids molecules and 9 kDa of polymer in addition to the protein) greatly simplifies the 
simulation system allowing longer simulations to be carried out.  
In conclusion,  these new encapsulation systems have the potential to revolutionise our knowledge of 
membrane protein structure and function and enhancing our understanding of biology at the atomic 
level. 
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